| Data | Hora | Fonte | Título | Código | Companhia |
| 18/07/2013 | 16:30 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 16:30 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 16:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 15:50 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 12:39 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 16/07/2013 | 13:00 | PR Newswire (US) | Omthera Stockholders Approve Acquisition by AstraZeneca | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 11/07/2013 | 10:13 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 09/07/2013 | 07:00 | PR Newswire (US) | Omthera Pharmaceuticals Announces NDA Submission for Epanova™ for the Treatment of Patients with Very High Triglycerides | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 27/06/2013 | 12:00 | PR Newswire (US) | Omthera Pharmaceuticals Announces Termination Of Antitrust Waiting Period | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 13/06/2013 | 13:54 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 13/06/2013 | 13:13 | PR Newswire (US) | Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 10/06/2013 | 06:20 | Dow Jones News | AstraZeneca Buys Pearl for $1.15 Billion | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 04/06/2013 | 18:12 | GlobeNewswire Inc. | OMTHERA PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors of Claims of Breaches of Fiduciary Duty by Board | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 03/06/2013 | 18:37 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (preliminary) (prem14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 30/05/2013 | 20:30 | Business Wire | Rigrodsky & Long, P.A. Investigates Omthera Pharmaceuticals, Inc. Buyout | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 30/05/2013 | 19:01 | PR Newswire (US) | Omthera Pharmaceuticals, Inc. Stockholders Seeking More Money, Information in Buyout Should Contact Deans & Lyons Law Firm | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 30/05/2013 | 18:47 | Business Wire | SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Omthera Pharmaceuticals, Inc. | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 30/05/2013 | 17:28 | PR Newswire (US) | OMTHERA PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible Breaches of Fiduciary Duty ... | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 29/05/2013 | 17:39 | Business Wire | Omthera Pharmaceuticals Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to AstraZeneca | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 29/05/2013 | 14:00 | PR Newswire (US) | SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Omthera Pharmaceuticals, Inc - OMTH | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 29/05/2013 | 13:06 | Business Wire | Law Firm Brower Piven Announces Investigation of Omthera Pharmaceuticals, Inc. Proposed Buyout | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 29/05/2013 | 11:47 | PR Newswire (US) | Ryan & Maniskas, LLP Announces Investigation of Omthera Pharmaceuticals, Inc. | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 29/05/2013 | 08:13 | Business Wire | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Omt... | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 28/05/2013 | 22:11 | PR Newswire (US) | Lifshitz Law Firm Announces Investigation of CapLease, Inc., Lender Processing Services, Inc., Omthera Pharmaceuticals, Inc. ... | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 28/05/2013 | 22:00 | Business Wire | OMTHERA PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Omthe... | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 28/05/2013 | 21:55 | PR Newswire (US) | Harwood Feffer LLP Announces Investigation of Omthera Pharmaceuticals, Inc. | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 28/05/2013 | 20:00 | Business Wire | Faruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Omthera Pharmaceuticals, Inc. (OMTH) Over the P... | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 28/05/2013 | 18:11 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 28/05/2013 | 15:21 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 28/05/2013 | 13:11 | Edgar (US Regulatory) | Semi-annual Report (management Company) (nsar-a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |